As of 4:00pm ET
| -0.18 / -4.39%|
The 3 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 15.00 and a low estimate of 11.00. The median estimate represents a +257.14% increase from the last price of 3.92.
The current consensus among 3 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.